nifedipine has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 2 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Takahashi, E | 1 |
Inanami, O | 1 |
Ohta, T | 1 |
Matsuda, A | 1 |
Kuwabara, M | 1 |
Sathiapalan, RK | 1 |
El-Solh, H | 1 |
1 review available for nifedipine and Precursor Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Enhanced vincristine neurotoxicity from drug interactions: case report and review of literature.
Topics: Child, Preschool; Drug Interactions; Drug Therapy, Combination; Female; Humans; Itraconazole; Neurot | 2001 |
1 other study available for nifedipine and Precursor Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Lipid raft disruption prevents apoptosis induced by 2-chloro-2'-deoxyadenosine (Cladribine) in leukemia cell lines.
Topics: Apoptosis; beta-Cyclodextrins; Calcium; Cell Line, Tumor; Chelating Agents; Cladribine; Drug Screeni | 2006 |